Alzheimer’s disease is one of the toughest medical issues that disrupts a person's daily life. Thankfully, medical advances ...
Variability in total cholesterol and low-density lipoprotein cholesterol is associated with dementia and cognitive impairment.
There have been several studies that have linked bacteria in the mouth to dementia. Research has generally suggested that ...
Alzheimer’s disease — which affects an estimated 7 million Americans — is notoriously difficult to detect, especially in its ...
A new biomarker test can detect early-stage tau protein clumping up to a decade before it appears on brain scans, improving early Alzheimer’s diagnosis. Unlike amyloid-beta, tau neurofibrillary ...
More than 2 years since the original trial data for lecanemab in Alzheimer's disease was published,1 and over 1·5 years since approval by the US Food and Drug Administration, brain volume data have ...
Alzheimer's patients with a baseline CDR-SB score of 3.5 could expect approximately 4 additional months (95% CI 2-7 months) ...
Friends or family members, including those who are caring for the person, can also be in denial and find a dementia diagnosis difficult to accept. It is not only people with dementia who may not ...
Researchers combined animal models, human brain tissue, and molecular analysis to uncover a connection between Alzheimer's ...
The mucopolysaccharidosis market is witnessing a surge in innovation, driven by cutting-edge gene therapies, enzyme replacement treatments, and novel drug developments. The market is poised for ...
POTOMAC, MARYLAND / ACCESS Newswire / February 18, 2025 / IGC Pharma, Inc. ("IGC" or the "Company") (NYSE American:IGC) today announced its financial results for the third fiscal quarter of 2025 ended ...
Researchers have developed a test that spots early signs of Alzheimer's disease. Rather than looking for amyloid-beta plaques ...